Obesity and Insulin Resistance Are the Main Determinants of Postprandial Lipoprotein Dysmetabolism in Polycystic Ovary Syndrome

Table 1

Baseline characteristics of all subjects ().

	PCOS; ()	Controls; ()
Age (yrs)	30.4 ± 1.2	34.1 ± 1.5	0.063
Systolic BP (mmHg)	126.3 ± 1.8	121.6 ± 2.5	0.131
Diastolic BP (mmHg)	79.0 ± 1.1	77.8 ± 2.3	0.652
Waist (cm)	112.0 ± 2.2	99.8 ± 2.4	<0.001
Hip (cm)	120.5 ± 1.7	110.9 ± 1.9	<0.001
Waist : Hip	0.930 ± 0.014	0.900 ± 0.014	0.139
Weight (kg)	95.4 ± 2.6	83.2 ± 2.8	0.003
BMI (kg/m^2)	36.8 ± 0.9	31.5 ± 1.0	<0.001
Smoking (%)	26	31	0.696
% Body fat mass (%)	40.4 ± 1.3	33.6 ± 2.0	0.006
T (nmol/L)	3.22 ± 0.30	1.57 ± 0.13	<0.001
SHBG (nmol/L)	29.8 ± 2.00	47.4 ± 3.48	<0.001
FAI	12.2 ± 1.59	3.67 ± 0.39	<0.001
Androstenedione (nmol/L)	15.58 ± 0.84	11.82 ± 0.84	0.003
DHEAS (μmol/L)	7.62 ± 0.71	4.98 ± 0.49	0.003
FSH (IU/L)	5.54 ± 0.35	8.93 ± 0.90	<0.001
LH (IU/L)	6.37 ± 0.74	7.49 ± 1.41	0.654
(μmol^2/L^2)	4.40 ± 0.41	2.56 ± 0.30	<0.001
(10^−4 min^−1/mU/L)	1.99 ± 0.18	4.05 ± 0.46	<0.001
(min^−1)	0.02 ± 0.00	0.02 ± 0.00	0.352
AIRG (mU⋅L^−1⋅min)	985 ± 171	613 ± 85	0.207
DI	1756 ± 281	2308 ± 358	0.226

-tests analysis after log transformation.